| Literature DB >> 33284427 |
Sibylle C Mellinghoff1,2,3, Sofie Schumacher1,2,3, Jon Salmanton-García1,2,3, Oliver A Cornely4,5,6,7,8.
Abstract
PURPOSE: Increasing influenza vaccination coverage in healthcare workers is a challenge. Especially during the ongoing COVID-19 pandemic, high vaccination coverage should be attained. This review analyzed strategies to increase influenza vaccination coverage in healthcare workers.Entities:
Keywords: Healthcare personnel; Immunization; Immunization programs; Influenza virus; Seasonal influenza; Vaccine uptake rate
Year: 2020 PMID: 33284427 PMCID: PMC7720031 DOI: 10.1007/s15010-020-01555-9
Source DB: PubMed Journal: Infection ISSN: 0300-8126 Impact factor: 3.553
Fig. 1Study selection flow. Flowchart showing the study selection after searching with the following predefined search algorithm on PubMed®: [(“health personnel/analysis” (MeSH Terms) OR “health personnel/statistics and numerical data” (MeSH Terms)] AND “influenza, human/prevention and control” (MeSH Terms)] NOT [review (Publication Type)]. Additionally, nine publications were found through references of relevant publications
Summary of interventions, study population, season (year) and vaccination coverage
| Publication | Country | Season | % VC | Relative increase | Key intervention | Key elements | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before | After | Average ± SD [Range] | [%] | Average ± SD [Range] [%] | ||||||
| Abramson et al. [ | Israel | 2007–08 | 163 | 27 | 53 | From 31.2 ± 26.3 [10–83] VC before, to 45.8 ± 27.3 [14–95] VC after | 96.3 | 65.9 ± 55.8 [14.5–162.5] | Education/ Promotion | Lecture, reminders, literature via e-mail, personal interaction |
| Borgey et al. [ | France | 2014–15 | 496 | 28 | 34 | 21.4 | Slide shows and posters | |||
| Costantino et al. [ | Italy | 2016–17 | 38 | 16 | 42 | 162.5 | Training course | |||
| Cozza et al. [ | Italy | 2012–13 | 1813 | 10 | 14 | 40.0 | Posters, fact sheets, online presence | |||
| Jung et al. [ | Korea | 2015–16 | 1433 | 83 | 95 | 14.5 | Education, one-on-one counselling, on site vaccination | |||
| Llupia et al. [ | Spain | 2008–09 | 4500 | 23 | 37 | 60.9 | Education, humorous pictures of vaccinated staff | |||
| Podczervisnki et al. [ | United States | 2011–12 | 1586 | 85 | 92 | From 85 VC before, to 92 VC after | 8.2 | 8.2 | Incentive | Incentive |
| Barbara et al. [ | Italy | 2016–17 | 1013 | 10 | 18 | From 11.0 ± 1.4 [10–13] VC Before, to 23.3 ± 11.2 [17–40] VC after | 80.0 | 113.6 ± 102.7 [30.8–263.6] | Organization | On site vaccination |
| Gilardi et al. [ | Italy | 2017–18 | 2131 | 13 | 17 | 30.8 | On site vaccination | |||
| Oguz et al. [ | Turkey | 2017–18 | 572 | 11 | 40 | 263.6 | On site vaccination | |||
| Vimercati et al. [ | Italy | 2017–18 | 700 | 10 | 18 | 80.0 | On site vaccination | |||
| Awali et al. [ | United States | 2011–12 | 3054 | 80 | 93 | From 74.0 ± 19.0 [40–99] VC before, to 87.8 ± 12.7 [58–99] VC after | 16.3 | 25.0 ± 31.3 [31.1–97.9] | Policy | Mandatory vaccination |
| Babcock et al. [ | United States | 2008–09 | 25,980 | 71 | 98 | 38.0 | Mandatory vaccination | |||
| Batabyal et al. [ | United States | 2008–09 | 29,000 | 48 | 66 | 37.5 | Declination form | |||
| Batabyal et al. [ | United States | 2009–10 | 29,000 | 66 | 90 | From 74.0 ± 19.0 [40–99] VC before, to 87.8 ± 12.7 [58–99] VC after | 36.4 | 25.0 ± 31.3 [31.1–97.9] | Policy | Mandatory vaccination |
| Batabyal et al. [ | United States | 2010–11 | 29,000 | 90 | 62 | − 31.1 | Declination form | |||
| Batabyal et al. [ | United States | 2011–12 | 29,000 | 62 | 62 | 0.0 | Declination form | |||
| Batabyal et al. [ | United States | 2012–13 | 29,000 | 62 | 86 | 38.7 | Declination form | |||
| Batabyal et al. [ | United States | 2013–14 | 29,000 | 86 | 92 | 7.0 | Declination form, vaccinate-or-mask | |||
| Batabyal et al. [ | United States | 2014–15 | 29,000 | 92 | 92 | 0.0 | Declination form, vaccinate-or-mask | |||
| Batabyal et al. [ | United States | 2015–16 | 29,000 | 92 | 96 | 4.3 | Declination form, vaccinate-or-mask | |||
| Esolen et al. [ | United States | 2009–10 | 12,363 | 47 | 90 | 91.5 | Vaccinate-or-mask | |||
| Esolen et al. [ | United States | 2010–11 | n.a | 90 | 92 | 2.2 | Vaccinate-or-mask | |||
| Esolen et al. [ | United States | 2011–12 | n.a | 92 | 95 | 3.3 | Vaccinate-or-mask | |||
| Esolen et al. [ | United States | 2012-–13 | 19,985 | 95 | 97 | 2.1 | Vaccinate-or-mask | |||
| Honda et al. [ | Japan | 2012–13 | 1616 | 87 | 97 | 11.5 | Declination form | |||
| Huynh et al. [ | United States | 2010–11 | 5300 | 68 | 96 | 41.2 | Mandatory vaccination | |||
| Kim et al. [ | United States | 2012–13 | n.a | 74 | 89 | 20.3 | Declination form, vaccinate-or-mask | |||
| Ksienski [ | Canada | 2012–13 | 48,818 | 40 | 74 | 85.0 | Vaccinate-or-mask | |||
| LaVela et al. [ | United States | 2013–14 | 173 | 54 | 77 | 42.6 | Declination form | |||
| Modak et al. [ | United States | 2011–12 | 2723 | 61 | 85 | 39.3 | Declination form, vaccinate-or-mask | |||
| Podczervisnki et al. [ | United States | 2012–13 | 1641 | 92 | 96 | From 74.0 ± 19.0 [40–99] VC before, to 87.8 ± 12.7 [58–99] VC after | 4.3 | 25.0 ± 31.3 [31.1–97.9] | Policy | Declination form |
| Quan et al. [ | United States | 2007–08 | 6414 | 44 | 63 | 43.2 | Declination form, decentralized distribution, flu mobile | |||
| Quan et al. [ | United States | 2008–09 | 6734 | 63 | 58 | − 7.9 | Declination form, decentralized distribution, flu mobile | |||
| Quan et al. [ | United States | 2009–10 | 6568 | 58 | 87 | 50.0 | Declination form, vaccinate-or-mask | |||
| Quan et al. [ | United States | 2010–11 | 6582 | 87 | 92 | 5.7 | Declination form, vaccinate-or-mask, incentive | |||
| Rakita et al. [ | United States | 2005–06 | 5000 | 54 | 98 | 81.5 | Mandatory vaccination | |||
| Rakita et al. [ | United States | 2006-–07 | 5000 | 98 | 99 | 1.0 | Mandatory vaccination | |||
| Rakita et al. [ | United States | 2007–08 | 5000 | 99 | 99 | 0.0 | Mandatory vaccination | |||
| Rakita et al. [ | United States | 2008–09 | 5000 | 99 | 99 | 0.0 | Mandatory vaccination | |||
| Rakita et al. [ | United States | 2009–10 | 5000 | 99 | 99 | 0.0 | Mandatory vaccination | |||
| Smith et al. [ | United States | 2011–12 | 30,000 | 71 | 97 | 36.6 | Mandatory vaccination | |||
| Stuart et al. [ | Australia | 2013 | 208 | 47 | 93 | 97.9 | Vaccinate-or-mask | |||
| Drees et al. [ | United States | 2011–12 | 10,286 | 66 | 92 | From 67.0 ± 21.1 [17–94] VC before, to 71.4 ± 28.0 [17–94] VC after | 39.4 | 14.4 ± 28.2 [-20–88.1] | Combined intervention | Declination form, vaccinate-or-mask, incentive, penalties, promotion, vaccination stations |
| Drees et al. [ | United States | 2012–13 | 10,388 | 92 | 94 | From 67.0 ± 21.1 [17–94] VC before, to 71.4 ± 28.0 [17–94] VC after | 2.2 | 14.4 ± 28.2 [− 20 to 88.1] | Combined intervention | Declination form, vaccinate-or-mask, incentive, penalties, promotion, vaccination stations |
| Drees et al. [ | United States | 2013–14 | 11,046 | 94 | 93 | − 1.1 | Declination form, vaccinate-or-mask, incentive, penalties, promotion, vaccination stations | |||
| Drees et al. [ | United States | 2014–15 | 10,883 | 93 | 93 | 0.0 | Declination form, vaccinate-or-mask, incentive, penalties, promotion, vaccination stations | |||
| Friedl et al. [ | Switzerland | 2003–04 | 1322 | n.a | 20 | n.a | Lectures, educational material, incentive | |||
| Friedl et al. [ | Switzerland | 2004–05 | 1163 | 20 | 17 | − 15.0 | Lectures, educational material, incentive | |||
| Friedl et al. [ | Switzerland | 2005–06 | 1236 | 17 | 30 | 76.5 | Educational material, promotional material | |||
| Friedl et al. [ | Switzerland | 2006–07 | 1290 | 30 | 24 | − 20.0 | On site vaccination, lectures, educational material | |||
| Friedl et al. [ | Switzerland | 2007–08 | 1415 | 24 | 27 | 12.5 | On site vaccination, educational material, incentive | |||
| Frisina et al. [ | United States | 2014–15 | 93 | 70 | 85 | 21.4 | On site vaccination, educational material, Plan-do-study-act | |||
| Frisina et al. [ | United States | 2015–16 | 90 | 85 | 91 | 7.1 | On site vaccination, educational material, Plan-do-study-act | |||
| Frisina et al. [ | United States | 2016–17 | 104 | 91 | 90 | From 67.0 ± 21.1 [17–94] VC before, to 71.4 ± 28.0 [17–94] VC after | − 1.1 | 14.4 ± 28.2 [-20–88.1] | Combined intervention | On site vaccination, educational material, Plan-do-study-act |
| Frisina et al. [ | United States | 2017–18 | 102 | 90 | 90 | 0.0 | On site vaccination, educational material, Plan-do-study-act | |||
| Gilardi et al. [ | Qatar | 2014–15 | n.a | 71 | 93 | 31.0 | On site vaccination, mobile cart, education emails, group meetings, declination form | |||
| Heinrich-Morrison et al. [ | Australia | 2014 | 7480 | 56 | 80 | 42.9 | Declination form, incentive, promotion, mass vaccination events | |||
| Horst-Schaper et al. [ | Germany | 2018–19 | 4000 | n.a | n.a | n.a | Promotion, education, on site vaccination, incentive | |||
| Marshall et al. [ | Australia | 2013 | 8000 | 42 | 79 | 88.1 | Declination form, incentive, “flu stop shop”, education | |||
| Marshall et al. [ | Australia | 2014 | 8000 | 79 | 80 | 1.3 | Declination form, incentive, “flu stop shop”, education | |||
| Marshall et al. [ | Australia | 2015 | 8000 | 80 | 79 | − 1.3 | Declination form, incentive, “flu stop shop”, education | |||
| Marshall et al. [ | Australia | 2016 | 8000 | 79 | 80 | 1.3 | Declination form, incentive, “flu stop shop”, education | |||
| Marshall et al. [ | Australia | 2017 | 8000 | 80 | 81 | 1.3 | Declination form, incentive, “flu stop shop”, education | |||
| Marshall et al. [ | Australia | 2018 | 8000 | 81 | 82 | 1.2 | Declination form, incentive, “flu stop shop”, education | |||
Table of each reviewed publication with corresponding country, season, study population, VC before and after intervention and key intervention. The vaccination campaigns were evaluated regarding key elements and subsequently grouped under key interventions: education/promotion, combined interventions, incentive, policy, and organization. The average initial and resulting VC ± SD and range in regard to the key interventions is given. Additionally, the relative increase in percent between initial and resulting VC for each season is given. Also, the relative increase (with ± SD and range) in percent for each key intervention overall is given. Out of the 32 studies included, 4 studies were controlled interventional studies (indicated with *). For these studies, only the intervention arm was considered when comparing the VC.
N study population, VC vaccination coverage, n.a. not available, SD standard deviation
Fig. 2Median variation of vaccination rates after the application of different policies and overall. VC, vaccination coverage. Line graph of the initial and final VC in regard to implemented key interventions and overall. Education/promotion (n = 6) included providing material and spreading awareness. Incentives (n = 1) included prize draws. Organization (n = 4) included on-site vaccination. Policies (n = 15) included mandatory vaccination, declination form and vaccinate-or-wear-a-mask approaches. Combined interventions (n = 7) included combinations of the aforementioned interventions. Concerning the four controlled interventional studies, only the intervention arm was considered when comparing the VC in regard to the key intervention